Neuronetics is a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Co.'s commercial product, NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical power designed to stimulate specific areas of the brain associated with mood. The system is used to treat adult patients with major depressive disorder (MDD) who have failed to achieve improvement from prior antidepressant medication in the existing MDD episode. The STIM average annual return since 2018 is shown above.
The Average Annual Return on the STIM average annual return since 2018 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether STIM average annual return since 2018 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the STIM average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|
Free STIM Email Alerts:
Video: Don't Forget Dividends in Average Annual Return!
